BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 30809031)

  • 1. Validation of treatment outcomes according to revised severity criteria from European Society for Blood and Marrow Transplantation (EBMT) for sinusoidal obstruction syndrome/veno-occlusive disease (SOS/VOD).
    Yoon JH; Yoo KH; Sung KW; Jung CW; Kim JS; Hahn SM; Kang HJ; Lee JH; Im HJ; Ahn JS; Kook H; Cho B; Lee JW
    Bone Marrow Transplant; 2019 Aug; 54(8):1361-1368. PubMed ID: 30809031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease after Autologous or Allogeneic Hematopoietic Stem Cell Transplantation in Children: a retrospective study of the Italian Hematology-Oncology Association-Hematopoietic Stem Cell Transplantation Group.
    Faraci M; Bertaina A; Luksch R; Calore E; Lanino E; Saglio F; Prete A; Menconi M; De Simone G; Tintori V; Cesaro S; Santarone S; Orofino MG; Locatelli F; Zecca M
    Biol Blood Marrow Transplant; 2019 Feb; 25(2):313-320. PubMed ID: 30266674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Earlier defibrotide initiation post-diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome improves Day +100 survival following haematopoietic stem cell transplantation.
    Richardson PG; Smith AR; Triplett BM; Kernan NA; Grupp SA; Antin JH; Lehmann L; Miloslavsky M; Hume R; Hannah AL; Nejadnik B; Soiffer RJ
    Br J Haematol; 2017 Jul; 178(1):112-118. PubMed ID: 28444784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of the refined EBMT diagnostic and severity criteria 2023 for sinusoidal obstruction syndrome/veno-occlusive disease.
    Ichikawa H; Yakushijin K; Kurata K; Tsuji T; Takemoto N; Joyce M; Okazoe Y; Takahashi R; Matsumoto S; Sakai R; Kitao A; Miyata Y; Saito Y; Kawamoto S; Yamamoto K; Ito M; Murayama T; Matsuoka H; Minami H
    Bone Marrow Transplant; 2024 Apr; 59(4):518-525. PubMed ID: 38287083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic veno-occlusive disease (sinusoidal obstruction syndrome) after hematopoietic stem cell transplantation in adult patients: Diagnosis, incidence, prophylaxis, and treatment.
    Özkan HA; Özkan SG
    Transfus Apher Sci; 2022 Feb; 61(1):103372. PubMed ID: 35101376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation.
    Dignan FL; Wynn RF; Hadzic N; Karani J; Quaglia A; Pagliuca A; Veys P; Potter MN; ;
    Br J Haematol; 2013 Nov; 163(4):444-57. PubMed ID: 24102514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transjugular Intrahepatic Portosystemic Shunt for Very Severe Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) after Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation with Post-transplantation Cyclophosphamide.
    Gómez-Centurión I; Bailén R; Oarbeascoa G; Muñoz C; Luque AÁ; Boyra ME; Calleja E; Rincón D; Dorado N; Barzallo P; Anguita J; Díez-Martín JL; Kwon M
    Biol Blood Marrow Transplant; 2020 Nov; 26(11):2089-2097. PubMed ID: 32791193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective Application of Sinusoidal Obstruction Syndrome/Veno-occlusive Disease Diagnostic Criteria in a Pediatric Hematopoietic Stem Cell Transplant Cohort.
    Dhir A; Wadhwa A; Haines H; Chewning J; Murthy S; Kim J; Beatty L; Mixon E; Fowler KB; Gage J; Meadows T; Goldman F
    J Pediatr Hematol Oncol; 2022 Mar; 44(2):e343-e348. PubMed ID: 35200220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defibrotide for Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome: Interim Results from a Treatment IND Study.
    Richardson PG; Smith AR; Triplett BM; Kernan NA; Grupp SA; Antin JH; Lehmann L; Shore T; Iacobelli M; Miloslavsky M; Hume R; Hannah AL; Nejadnik B; Soiffer RJ;
    Biol Blood Marrow Transplant; 2017 Jun; 23(6):997-1004. PubMed ID: 28285079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early Clinical Predictors of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Myeloablative Stem Cell Transplantation.
    Roeker LE; Kim HT; Glotzbecker B; Nageshwar P; Nikiforow S; Koreth J; Armand P; Cutler C; Alyea EP; Antin JH; Richardson PG; Soiffer RJ; Ho VT
    Biol Blood Marrow Transplant; 2019 Jan; 25(1):137-144. PubMed ID: 30081073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current incidence, severity, and management of veno-occlusive disease/sinusoidal obstruction syndrome in adult allogeneic HSCT recipients: an EBMT Transplant Complications Working Party study.
    Ruutu T; Peczynski C; Houhou M; Polge E; Mohty M; Kröger N; Moiseev I; Penack O; Salooja N; Schoemans H; Duarte RF; Schroeder T; Passweg J; Wulf GG; Ganser A; Sica S; Arat M; Salmenniemi U; Broers AEC; Bourhis JH; Rambaldi A; Maertens J; Halaburda K; Zuckerman T; Labussière-Wallet H; Basak G; Koenecke C; Perić Z
    Bone Marrow Transplant; 2023 Nov; 58(11):1209-1214. PubMed ID: 37573397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic sinusoidal obstruction syndrome/veno-occlusive disease after hematopoietic cell transplantation: historical and current considerations in Korea.
    Yoon JH; Choi CW; Won JH
    Korean J Intern Med; 2021 Nov; 36(6):1261-1280. PubMed ID: 34555279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation.
    Mohty M; Malard F; Abecassis M; Aerts E; Alaskar AS; Aljurf M; Arat M; Bader P; Baron F; Bazarbachi A; Blaise D; Ciceri F; Corbacioglu S; Dalle JH; Dignan F; Fukuda T; Huynh A; Masszi T; Michallet M; Nagler A; NiChonghaile M; Okamoto S; Pagliuca A; Peters C; Petersen FB; Richardson PG; Ruutu T; Savani BN; Wallhult E; Yakoub-Agha I; Duarte RF; Carreras E
    Bone Marrow Transplant; 2016 Jul; 51(7):906-12. PubMed ID: 27183098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SINUSOIDAL OBSTRUCTION SYNDROME/VENO-OCCLUSIVE DISEASE AFTER UNMANIPULATED HAPLOIDENTICAL HSCT WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE: A STUDY ON BEHALF OF THE SPANISH HEMATOPOIETIC STEM CELL TRANSPLANTATION AND CELLULAR THERAPY GROUP (GETH).
    Gómez-Centurión I; Gallardo Morillo AI; Pérez Martínez A; Cabrero Calvo M; Chinea A; González L; Pedraza A; Jiménez Lorenzo MJ; Robles MC; Bailén R; Cascón MJP; Cabero A; Piñana Sánchez JL; Luna A; Perera Alvarez M; Rovira M; Torrent Catarineu A; Sánchez-Pina J; Kwon M
    Transplant Cell Ther; 2024 Jun; ():. PubMed ID: 38851323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a refined classification from the European society for blood and marrow transplantation (EBMT).
    Mohty M; Malard F; Alaskar AS; Aljurf M; Arat M; Bader P; Baron F; Bazarbachi A; Blaise D; Brissot E; Ciceri F; Corbacioglu S; Dalle JH; Dignan F; Huynh A; Kenyon M; Nagler A; Pagliuca A; Perić Z; Richardson PG; Ruggeri A; Ruutu T; Yakoub-Agha I; Duarte RF; Carreras E
    Bone Marrow Transplant; 2023 Jul; 58(7):749-754. PubMed ID: 37095231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and marrow transplantation.
    Corbacioglu S; Carreras E; Ansari M; Balduzzi A; Cesaro S; Dalle JH; Dignan F; Gibson B; Guengoer T; Gruhn B; Lankester A; Locatelli F; Pagliuca A; Peters C; Richardson PG; Schulz AS; Sedlacek P; Stein J; Sykora KW; Toporski J; Trigoso E; Vetteranta K; Wachowiak J; Wallhult E; Wynn R; Yaniv I; Yesilipek A; Mohty M; Bader P
    Bone Marrow Transplant; 2018 Feb; 53(2):138-145. PubMed ID: 28759025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver Stiffness Measurement Allows Early Diagnosis of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome in Adult Patients Who Undergo Hematopoietic Stem Cell Transplantation: Results from a Monocentric Prospective Study.
    Colecchia A; Ravaioli F; Sessa M; Alemanni VL; Dajti E; Marasco G; Vestito A; Zagari RM; Barbato F; Arpinati M; Cavo M; Festi D; Bonifazi F
    Biol Blood Marrow Transplant; 2019 May; 25(5):995-1003. PubMed ID: 30660772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Prophylaxis of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome With Defibrotide After Hematopoietic Stem Cell Transplantation in Children: Single Center Experience.
    Karagun BS; Akbas T; Erbey F; Sasmaz İ; Antmen B
    J Pediatr Hematol Oncol; 2022 Jan; 44(1):e35-e39. PubMed ID: 34966102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sinusoidal obstruction syndrome/veno-occlusive disease after high-dose intravenous busulfan/melphalan conditioning therapy in high-risk Ewing Sarcoma.
    Abate ME; Paioli A; Cammelli S; Cesari M; Longhi A; Palmerini E; Ferrari S; Carretta E; Picci P; Piscaglia F
    Bone Marrow Transplant; 2018 May; 53(5):591-599. PubMed ID: 29335623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis and treatment of sinusoidal obstruction syndrome (veno-occlusive disease)].
    Kikuta A
    Rinsho Ketsueki; 2021; 62(8):1256-1264. PubMed ID: 34497214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.